Inventage Lab인벤티지랩
389470 · KOSDAQ · ₩389470 · 인벤티지랩
₩23,000▼ ₩950 (3.97%)End-of-day · Oct 29, 2026 · End-of-day prices.
Income statement
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Revenue | ₩176M | ₩393M | ₩1.1B | ₩832M | ₩865M | ₩169M | ₩1.1B | ₩218M |
| Cost of sales | ₩1.9B | ₩1.3B | ₩1.9B | ₩1.7B | ₩2.2B | ₩1.3M | ₩14M | ₩3.1M |
| Gross profit | −₩1.7B | −₩955M | −₩871M | −₩894M | −₩1.3B | ₩168M | ₩1.1B | ₩215M |
| Operating income | −₩10B | −₩8.4B | −₩7.5B | −₩7.4B | −₩8.1B | −₩5.4B | −₩5.4B | −₩5.4B |
| Net income | −₩5.1B | ₩923M | −₩9.4B | −₩6.2B | ₩7.9B | −₩8.2B | −₩5.5B | −₩9.2B |
| Net income to shareholders | −₩2.4B | ₩3B | ₩1B | −₩4.8B | ₩3.4B | −₩8.2B | −₩5.5B | −₩9.2B |
Balance sheet
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Total assets | ₩194B | ₩215B | ₩111B | ₩113B | ₩116B | ₩120B | ₩72B | ₩77B |
| Current assets | ₩121B | ₩141B | ₩40B | ₩43B | ₩46B | ₩51B | ₩49B | ₩53B |
| Cash and equivalents | ₩98B | ₩107B | ₩14B | ₩22B | ₩31B | ₩28B | ₩17B | ₩23B |
| Total liabilities | ₩83B | ₩100B | ₩30B | ₩39B | ₩60B | ₩62B | ₩40B | ₩37B |
| Current liabilities | ₩42B | ₩60B | ₩20B | ₩29B | ₩14B | ₩17B | ₩11B | ₩11B |
| Borrowings | ₩29B | ₩28B | ₩14B | ₩21B | ₩28B | ₩29B | ₩8.5B | ₩7.8B |
| Total equity | ₩111B | ₩115B | ₩81B | ₩73B | ₩57B | ₩58B | ₩33B | ₩39B |
| Shareholders' equity | ₩88B | ₩90B | ₩64B | ₩60B | ₩41B | ₩36B | ₩33B | ₩39B |
Cash flow
| Q2 2026 | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | |
|---|---|---|---|---|---|---|---|---|
| Cash from operations | −₩7.3B | −₩1.8B | −₩6.6B | −₩7.5B | −₩2.5B | −₩4.1B | −₩4.9B | −₩4.3B |
| Capital spending | ₩482M | ₩4.3B | ₩3.5B | ₩681M | ₩858M | ₩167M | ₩343M | ₩1.2B |
| Free cash flow | −₩7.8B | −₩6.1B | −₩10B | −₩8.2B | −₩3.4B | −₩4.3B | −₩5.3B | −₩5.4B |
Consolidated where available. Amounts in won.
Also known as: Inventage Lab / 인벤티지랩 / 389470 / KRX:389470
Source: KRX statistical information